While a vast majority of studies characterize how a single gene is modulated by upstream splicing factor alteration to promote cancer progression, the regulatory effects of splicing factors should be viewed as an entirety where splicing factors act on a set of genes to modulate certain aspects of tumor biology. The gene discussed is SLU7; the disease is neoplasm.